We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
Learn about Erleada (apalutamide) for prostate cancer, including its dosage, how it works, common and serious side effects, and when to consult a doctor. This guide is tailored for Indian readers.

Prostate cancer is a significant health concern for many men, and understanding the treatment options available is crucial. Erleada, with its active ingredient apalutamide, is a prescription medication used to manage certain types of prostate cancer. This blog post aims to provide a comprehensive overview of Erleada, focusing on its dosage, how it works, potential side effects, and important considerations for patients in India.
Erleada belongs to a class of drugs known as anti-androgens. It is specifically prescribed for adult males diagnosed with prostate cancer. The primary mechanism of action for Erleada is to block the effects of androgens, which are male sex hormones like testosterone. Prostate cancer cells often rely on these hormones to grow and spread. By reducing the availability or impact of androgens, Erleada helps to slow down or stop the growth of these cancer cells.
Erleada is indicated for two main types of prostate cancer:
Erleada is available in two strengths: 60 milligrams (mg) and 240 mg tablets. The usual recommended dosage for Erleada is 240 mg once per day. Depending on the doctor's prescription, this can be taken as:
It is essential to take Erleada exactly as prescribed by your doctor. Do not crush or split the tablets unless specifically instructed by your healthcare provider. The tablets are meant to be swallowed whole.
If you experience difficulty swallowing the tablets, inform your doctor immediately. They may prescribe the 60-mg tablets, which are slightly smaller than the 240-mg tablets. In some cases, if the 240-mg tablet is prescribed, your doctor might provide specific instructions on how to prepare it for administration:
Note: Always follow your doctor's specific instructions regarding the preparation and administration of Erleada.
Like all medications, Erleada can cause side effects. It is important to discuss these with your doctor. Some common side effects may include:
More serious side effects can occur, although they are less common. These may include:
If you experience any severe or persistent side effects, contact your doctor immediately. Your doctor may adjust your dosage or recommend other management strategies.
If you develop a severe side effect while taking Erleada, your doctor will likely advise you to stop the medication temporarily. Once the side effect is managed and you have recovered, your doctor may suggest restarting Erleada at a lower dose, typically 120 mg or 180 mg per day, to minimize the risk of recurrence.
Erleada can be prescribed for long-term use if it is effectively controlling your prostate cancer and you are not experiencing significant side effects. The goal of the medication is to slow or stop the progression of the cancer. If your cancer is stable and your quality of life is maintained, your doctor may continue your prescription for an extended period. Always discuss your concerns about long-term treatment with your healthcare provider.
It is crucial to consult your doctor before starting Erleada to ensure it is the right treatment for your specific condition. You should also seek medical advice if:
Disclaimer: This information is for educational purposes only and does not substitute professional medical advice. Always consult with a qualified healthcare provider for any health concerns or before making any decisions related to your health or treatment.

Discover 3 subtle signs of mouth cancer often dismissed as minor issues. Learn why early detection is crucial for effective treatment.
April 23, 2026
Learn about potential side effects of CML treatments like TKIs, interferon, chemotherapy, and stem cell transplants. Understand what to expect and how to communicate with your doctor for effective management.
April 1, 2026

Discover essential support resources, financial aid options, and community connections for individuals navigating life with Chronic Myeloid Leukemia (CML). Find practical advice and empathetic guidance.
April 1, 2026